AMY-101

AMY-101 · Amyndas Pharmaceuticals S.A.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AMY-101, covering 2021-02-21 to 2021-02-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the C3 Inhibitor AMY-101 in Patients With ARDS Due to COVID-19 (SAVE) [Phase 2]